DD
MM
YYYY

PAGES

DD
MM
YYYY

spot_img

PAGES

Home Blog Page 25

Lidar vs Camera-only: Waymo Again Stirs Debate About Best Tech for Robotaxi As Tesla Nears Cybercab Launch

0

Waymo has stepped up its criticism of camera-only autonomous driving, explaining that fully driverless vehicles need a combination of sensors to operate safely at scale, an apparent challenge to Tesla’s strategy just days before the expected unveiling of its purpose-built Cybercab.

The Alphabet-owned autonomous driving company said in a blog post last week that cameras alone are insufficient for full autonomy and warned that so-called pure end-to-end artificial intelligence systems can produce unpredictable failures. Although Waymo did not name Tesla, the comments directly target the approach used by Elon Musk’s electric vehicle maker, which has rejected lidar and relies primarily on cameras and AI.

The timing has intensified the rivalry between the companies. Tesla is expected to formally introduce the two-seat Cybercab at an event on September 3, while Waymo announced three additional markets on Tuesday as it expands a commercial robotaxi operation that now serves customers in more than a dozen U.S. cities.

What was once largely a technical debate over competing approaches to autonomous driving has become a commercial contest. Both companies are betting on a market that could eventually generate hundreds of billions of dollars, but they are pursuing radically different paths to reach it.

“Cameras are incredible, but they aren’t enough,” Srikanth Thirumalai, a Waymo vice president overseeing driving software, wrote in the company’s blog.

“Now, after more than 200 million real-world miles, the data is clear: safe, fully autonomous operations at scale require more,” he added, noting that combining cameras, lidar and radar gives the vehicle a redundant view of its surroundings that a single sensor type cannot provide.

Waymo’s argument rests heavily on operational experience. The company says it has accumulated more than 200 million real-world autonomous miles and operates roughly 4,000 robotaxis across 14 U.S. cities, providing about 500,000 paid trips a week.

Tesla, by comparison, has only recently begun expanding its own robotaxi service beyond limited trials. Its network has so far operated in a small number of Texas and Florida markets using modified Model Y vehicles, with the company saying it is prioritizing safety over rapid expansion.

The technological disagreement is fundamental.

Waymo uses a sensor suite combining cameras, lidar and radar, alongside sophisticated AI and mapping systems. The approach is designed around redundancy: if one sensor has difficulty interpreting an object or environment, other sensors can provide additional information.

Tesla has taken the opposite route. Musk has repeatedly dismissed lidar as a “crutch” and has argued that cameras, neural networks and sufficient computing power can provide everything required for autonomous driving.

Waymo now argues that this AI-first strategy carries a potentially dangerous weakness.

Thirumalai said a pure end-to-end system that takes raw camera images and directly produces steering commands could be vulnerable to “black box failures,” where the system’s decision-making becomes difficult to understand or predict.

“Even the best AI models with trillions of parameters still hallucinate,” he told Axios. “There is no click reboot or reload or refresh [in] physical AI. You have to deal with the consequences of it.”

The argument has been largely supported because while an error in a chatbot can generally be corrected with another response, an error by an autonomous vehicle can cause a collision within seconds. That prompts the question about whether AI can drive reliably enough across millions of journeys and unpredictable real-world conditions.

Tesla’s upcoming Cybercab provides a particularly important test of that proposition. The vehicle is a purpose-built two-seater designed from the outset for autonomous operation. It has no conventional steering wheel or pedals and is expected to have a relatively small battery compared with Tesla’s existing vehicles.

Tesla has also signaled ambitions for large-scale production. A recent filing indicates a target of more than 125,000 Cybercabs annually, although the company’s ability to reach that level will depend on regulatory approval, manufacturing readiness and the performance of its autonomous software.

Tesla has considerable ground to make up. Musk previously predicted that Tesla would have 1 million robotaxis operating by 2020, a target that was not achieved. The company has instead spent the past year conducting limited commercial trials and has only recently begun removing safety monitors from most of those vehicles.

Tesla has also begun registering Cybercabs with the Texas Department of Motor Vehicles ahead of Thursday’s event. Dozens of vehicles have reportedly been spotted in parking areas around the United States, suggesting the company is preparing for a broader deployment, although the timing and scale remain uncertain.

The stakes for Tesla extend beyond the launch itself. If its camera-only system can deliver reliable autonomous driving at commercial scale, the company could demonstrate that a less hardware-intensive approach can outperform or undercut Waymo’s more sensor-heavy model.

That is where the economics of the technology become as important as the engineering.

Waymo’s system is expensive. Lidar, radar, and additional computing hardware add to vehicle costs, while the company generally deploys its autonomous technology on vehicles manufactured by third parties. Waymo therefore has to purchase those vehicles and then retrofit them with its autonomous-driving hardware and software.

Tesla has a structural advantage if its AI approach works. It manufactures its own vehicles, controls much of the vehicle software and hardware stack, and could potentially integrate autonomous-driving technology during production rather than retrofit cars afterward.

That could give Tesla substantially lower costs per robotaxi.

The company is effectively making a high-risk technological bet: invest heavily in AI and computing to eliminate expensive sensors and simplify the hardware required for autonomous driving.

Waymo is making the opposite calculation. It is accepting higher hardware costs in exchange for additional sensing capability and redundancy.

Neither strategy has yet definitively won the argument.

Tesla still has to demonstrate that its autonomous system can operate reliably across a much wider range of conditions, including severe weather, unusual road layouts, emergency vehicles, pedestrians, construction zones and school areas. These are precisely the types of situations Waymo encounters as it operates a larger commercial fleet.

Waymo’s advantage is therefore its accumulated operational data and experience. Tesla’s potential advantage is scale and cost.

The confrontation also explains the increasingly pointed rhetoric between the two camps. Pierre Ferragu, an analyst and managing partner at New Street Research who covers Tesla, accused Waymo of falling into the rhetoric of an incumbent whose technology could eventually be made obsolete by advances in AI.

Waymo spokesperson Ethan Teicher responded by emphasizing the company’s accumulated driverless mileage, AI monitoring, and multi-sensor architecture.

The debate is ultimately about more than whether lidar is necessary or whether end-to-end AI is superior. It is about which architecture can deliver autonomous transportation at the lowest cost while maintaining an acceptable level of safety.

If Waymo is right, Tesla’s decision to abandon lidar could leave it exposed when autonomous systems encounter situations that cameras and AI struggle to interpret. If Tesla succeeds, however, the cost advantage of its vertically integrated manufacturing model could become a major competitive threat to Waymo and other robotaxi operators.

The September 3 Cybercab event will therefore be watched not simply as another Tesla product launch, but as a test of two competing visions for the future of autonomous transportation.

Hedge Fund Talent War Intensifies Between Citadel and Rivals

0

Citadel’s legal battle with a former portfolio manager has taken another turn, pulling one of the world’s biggest hedge funds deeper into a dispute that now reaches beyond the former employee himself.

What began as a fight over an executive’s departure and employment restrictions has increasingly become a broader confrontation over recruitment, confidential information and the fierce competition for investment talent on Wall Street.

The dispute centers on Daniel Shatz, a former Citadel portfolio manager who left the firm in 2023 and later joined Marshall Wace as its global head of credit. Citadel has alleged that Shatz violated obligations tied to his departure, including restrictions surrounding his move to a rival firm.

The disagreement has developed into an arbitration and court battle, with Citadel seeking evidence that could establish how Shatz was recruited and whether confidential information was involved.

Now the case has become messier because Citadel is seeking to bring senior figures at Marshall Wace into the dispute.

The firm is asking a court to compel Anthony Clake and Alan Hofmeyr, two prominent Marshall Wace executives, to turn over communications relating to Shatz’s recruitment. Citadel argues that the executives were involved in the hiring process and therefore may possess information relevant to its claims.

That demand puts the spotlight on a fundamental reality of the hedge-fund industry: people are intellectual capital. A portfolio manager does not simply leave with a résumé and a list of professional contacts.

They may carry years of experience, investment processes, relationships and knowledge of how a competing firm operates. For the firms involved, protecting that information can be just as important as protecting trading algorithms or proprietary research.

Marshall Wace has pushed back against Citadel’s demands. According to reports, the firm has provided limited evidence, including a single text message involving a Marshall Wace executive, while resisting a broader search for communications.

The argument is partly about burden and the scope of Citadel’s requests, but it also reflects the larger tension between legitimate protection of confidential information and aggressive litigation tactics.

The underlying arbitration adds another layer. Shatz has reportedly made his own claims against Citadel concerning compensation that he says was withheld after he raised concerns about potential securities-law violations.

That means the dispute is not simply Citadel pursuing a former employee; both sides have competing allegations and financial interests at stake.

The stakes extend beyond the individuals involved. Marshall Wace has been trying to build its credit business, with Shatz playing a central role in that expansion.

The legal confrontation therefore arrives at a sensitive moment for the firm. Reports have also described departures and internal tensions within the relatively young credit operation, adding pressure to an already complicated expansion.

The case represents another example of how seriously the firm treats employee departures and proprietary information. Hedge funds compete relentlessly for the best traders and portfolio managers, but every major hire can create legal risk when an employee crosses from one powerhouse to another.

What makes this battle particularly revealing is that neither side can easily treat it as just another employment dispute. Citadel wants to protect its interests and establish what happened around Shatz’s move.

Marshall Wace has an interest in defending its recruitment practices and limiting what could become an expansive examination of internal communications. As the legal fight widens, the courtroom is becoming another arena in the hedge-fund talent war.

Behind the financial headlines and enormous trading books lies a simpler contest: who owns the knowledge, relationships and competitive advantage created by an investment professional? In that world, a resignation may be the beginning of the battle, not the end.

OpenAI Integrates Chatgpt Health With Epic, Bringing AI Deeper Into Clinical Workflows

0

OpenAI is expanding ChatGPT into healthcare by integrating ChatGPT Health with Epic’s electronic health record system, giving clinicians access to patient information and AI-assisted analysis across medical records covering more than 325 million patients.

The integration will allow clinicians to import information from Epic and use ChatGPT to analyze and summarize appointment notes, laboratory results, medications, specialist documentation, and other elements of a patient’s medical history.

In some healthcare systems, OpenAI said ChatGPT will be embedded directly into existing electronic health record workflows, allowing clinicians to conduct pre-visit reviews and build clinical timelines without leaving a patient chart.

The company said the integration is strictly read-only. ChatGPT can retrieve and analyze information from the medical record, but the AI does not write information back into the patient’s chart.

The move marks a significant expansion of OpenAI’s healthcare strategy. Rather than limiting ChatGPT to a consumer-facing tool for answering health questions, the company is positioning its models as an interface for accessing and synthesizing information already held within clinical systems.

For physicians, one potential benefit is reducing the time required to review fragmented patient histories before appointments. A clinician could use the system to summarize previous consultations, track changes in laboratory results or medications, and assemble information from different specialists into a single timeline.

OpenAI is also introducing a Healthcare Public Data plugin that can retrieve information from medical and government databases, including ClinicalTrials.gov, the Centers for Medicare & Medicaid Services’ coverage information, RxNorm, DailyMed and PubMed.

The company said the plugin can help healthcare professionals synthesize information involving clinical-trial eligibility, medication identifiers, coverage policies and provider records.

OpenAI is further allowing organizations that have a Business Associate Agreement with the company to use ChatGPT Work, Codex, apps and connectors for healthcare-related workflows designed to meet applicable compliance requirements.

The expansion comes as OpenAI reports rapidly increasing use of ChatGPT for health-related questions. The company said users are now submitting about 300 million health queries each week, up from 230 million when it began testing its dedicated health hub in January.

The consumer health service is available to U.S.-based users aged 18 and older across ChatGPT plans. Users can connect information from services including Apple Health, Function and MyFitnessPal, as well as medical records from systems and providers such as Epic, Oracle Health, One Medical and Function Health.

OpenAI said testing showed that about 70% of health-related conversations occurred outside the dedicated health hub. The company is therefore expanding access to connected health information across general ChatGPT conversations, allowing users, for example, to ask questions about food while drawing on information about their allergies or other connected health data.

Safety Remains A Major Concern

The expansion also puts greater scrutiny on the reliability of AI in medical settings.

OpenAI said it collected more than 4,300 physician assessments across 27 clinical use cases, including pre-visit reviews, clinical timelines, medication reviews and patient handoff summaries. It said 99.1% of the responses were judged safe.

That figure nevertheless leaves room for potentially consequential errors. In healthcare, a small number of unsafe recommendations can have serious consequences, particularly when users interpret an AI response as medical advice.

OpenAI has maintained that ChatGPT is not intended to replace clinicians or independently diagnose or treat patients. The company’s growing integration with medical records, however, brings its technology closer to decisions and workflows where errors can carry substantially greater risks than in ordinary consumer applications.

The timing also places the rollout under heightened scrutiny. OpenAI is facing lawsuits over alleged harmful health advice, including a case filed by a Florida pastor who claims ChatGPT gave him a recommendation that nearly proved fatal. In another lawsuit filed in May, family members of a user alleged that ChatGPT provided incorrect advice involving medication dosage.

The Epic integration therefore represents both a technological and commercial test for OpenAI. Access to large-scale clinical data could make ChatGPT substantially more useful to healthcare professionals, while the read-only architecture gives hospitals a degree of separation between AI-generated analysis and the underlying medical record.

Overall, OpenAI is seeking to move ChatGPT from a standalone conversational application into an AI layer that can sit on top of the systems professionals already use. Healthcare, where clinicians routinely spend significant time navigating large volumes of fragmented information, could become one of the most consequential applications of that approach.

At the same time, the closer ChatGPT gets to clinical workflows, the higher the standard for accuracy, privacy, security, and human oversight will become.

U.S. Firm to Take Over Chinese, Russian-Linked Venezuelan Oilfields Under Trump-Backed Deal

0

U.S. oil company North American Blue Energy Partners (NABEP) is set to take control of several Venezuelan oilfields previously operated by Chinese companies and a Russian firm under a sweeping production agreement announced by President Donald Trump, according to two U.S. officials familiar with the arrangement cited by Reuters.

The deal gives Washington and U.S.-backed companies a significantly larger role in Venezuela’s oil industry, potentially displacing Chinese and Russian interests that have built a substantial presence in the country’s energy sector over the past decade.

NABEP has received 14 newly granted contracts from the Venezuelan authorities, the officials said. The projects form part of a broader portfolio that will give the company control of 17 oil projects in Venezuela, which it plans to develop and ultimately use to supply crude to the United States.

The arrangement is also structured to give the U.S. government an unusual degree of influence over the company and its production.

NABEP said it will retain operating control, while the U.S. government will hold rights to a 35% stake in the company and receive preferential access to 20% of its production at cost. The White House said the State Department will also have the right of first refusal to purchase the remaining 80% of NABEP’s output.

Washington will have veto power over NABEP’s board and director appointments, while a majority of the board must be American citizens, according to the White House.

“This transaction will unleash that potential to the great benefit of both Venezuelans and Americans,” Venezuelan businessman Alejandro Betancourt, who now controls NABEP, said in a statement confirming the arrangement.

The agreement marks a major shift in the ownership and destination of Venezuelan crude. Five of the 14 newly awarded fields were previously operated by Chinese companies under a model promoted by then-President Nicolas Maduro, while another was previously operated by a Russian company, the U.S. officials said.

Two of the fields were operated by China Concord Resources, which was sanctioned by the United States in 2019 over Iran-related activities. Other projects were previously operated by Sinopec and China National Petroleum Corp.

Two additional projects were operated by affiliates of Alex Saab, a former close associate of Maduro who is currently in U.S. custody, while another oilfield was linked to a nephew of Maduro’s wife, Cilia Flores, according to the officials.

The changes underscore the geopolitical dimension of Trump’s Venezuela oil strategy. Rather than simply increasing U.S. access to Venezuelan crude, the arrangement is seen as reducing the role of Chinese and Russian companies in one of the world’s largest oil-producing countries while redirecting more Venezuelan production toward U.S. refiners.

“Not only are we opening up new opportunities for the U.S. government to benefit and for U.S. operators to benefit, we are opening up the United States as the market for this oil which was previously being sent to China,” one U.S. official said.

Trump said last week that the United States had secured access to about 64 billion barrels of Venezuela’s proven oil reserves through a partnership with private businesses. The scale of the arrangement places Venezuela’s enormous but underdeveloped petroleum resources at the center of the administration’s effort to reshape the country’s economy and strengthen U.S. influence over its energy exports.

Trump said Monday that the United States was taking out “millions and millions of barrels of oil” that are currently being shipped to U.S. refineries, including facilities in Texas and Louisiana. He is scheduled to meet oil and gas retailers and refiners on Tuesday.

The potential increase in Venezuelan crude supplies could also have implications for U.S. refiners. Venezuela produces heavy crude that is suited to some Gulf Coast refineries, meaning a larger and more predictable flow of Venezuelan barrels could strengthen feedstock supplies for plants configured to process heavier grades.

The arrangement, however, depends on more than access to reserves. Venezuela’s oil industry has suffered years of underinvestment, declining production capacity, deteriorating infrastructure and operational disruptions. Bringing the newly transferred fields back to higher output levels will require significant capital, equipment and technical expertise.

The political transition in Caracas could prove equally important.

U.S. officials said talks are under way between Venezuela’s interim authorities and representatives of the 2015 National Assembly, with the aim of restoring a measure of constitutional order and resolving legal questions surrounding the country’s political transition.

The Trump administration regards the 2015 assembly as the last Venezuelan legislative body elected and operating under the country’s constitution, although it does not currently hold formal governing authority.

One U.S. official said an agreement with the assembly could provide a constitutional and legal foundation for the wider transition, including economic decisions required to revive Venezuela’s oil industry.

That makes the oil arrangement both an energy and geopolitical project. However, the immediate objective for Washington is greater access to Venezuelan crude and a larger U.S. role in its production and marketing. Energy analysts believe the longer-term test hinges on the new structure’s ability to attract the investment needed to restore Venezuela’s oil output while establishing a politically and legally durable framework for control of the country’s petroleum assets.